Lilly's Omvoh Demonstrated Early And Sustained Improvement In Bowel Urgency Outcomes For Patients With Ulcerative Colitis
I'm PortAI, I can summarize articles.
Eli Lilly and Co :LILLY'S OMVOH (MIRIKIZUMAB-MRKZ) DEMONSTRATED EARLY AND SUSTAINED IMPROVEMENT IN BOWEL URGENCY OUTCOMES FOR PATIENTS WITH ULCERATIVE COLITISELI LILLY - 55% REDUCTION IN BOWEL URGENCY EPISODES BY WEEK 12ELI LILLY - NO NEW SAFETY SIGNALS OBSERVED FOR OMVOH IN UC PATIENTS
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments